Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 20Genitourinary 19Thoracic 18Head & Neck 15Gastrointestinal 15Lymphoid 12Breast 12Sarcoma 10Tumor-Agnostic 3Other hematologic neoplasm 3Plasma cell 1Other solid neoplasm 1Gynecologic 1Dermatologic 1

Conditions

Skin Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 24Specimen Handling 21Nivolumab 20Magnetic Resonance Spectroscopy 16Ipilimumab 12Biopsy 9Cyclophosphamide 5CTLA-4 Antigen 5relatlimab 4Opdualag 4HhAntag691 4trametinib 3fludarabine 3dabrafenib 3cemiplimab 3binimetinib 3avelumab 3aldesleukin 3Surgical Procedures, Operative 3Radiosurgery 3Paclitaxel 3Cisplatin 3Carboplatin 3talimogene laherparepvec 2omipalisib 2capivasertib 2atezolizumab 2X-Rays 2Taxes 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiotherapy × Dermatologic × 30 days × Clear all
NCT05574101 2026-05-15

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
34 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡